:: Library Catalog

Copertina

Salvato in:

Dettagli Bibliografici
Autori principali:	Peter T. Katzmarzyk, Kimberly Drews, Jamy D. Ard, Tracey L. McLaughlin, Melissa N. Harris, Alexandra Lee, Gary D. Foster, Hyun Jung Lee, Timothy C. Dunn, Corby K. Martin, Frank L. Greenway, Michelle I. Cardel
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	Obesity
Accesso online:	https://onlinelibrary.wiley.com/doi/10.1002/oby.70204
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Twelve‐month analysis of real‐world evidence from a telehealth obesity‐treatment provider using antiobesity medications
di: Jamy D. Ard, et al.
Pubblicazione: (2024)

The latest evidence and clinical guidelines for use of meal replacements in very‐low‐calorie diets or low‐calorie diets for the treatment of obesity
di: Shenelle A. Edwards‐Hampton, et al.
Pubblicazione: (2024)

Computed Tomography and Dual‐Energy X‐Ray Asorptiometry body composition parameter harmonisation to universalise adipose tissue measurements in a population‐based cross‐sectional study
di: Elliot T. Varney, et al.
Pubblicazione: (2024)

Effects of a 2‐Year Primary Care Weight Loss Intervention on Quality of Life in Patients With Obesity
di: Kara D. Denstel, et al.
Pubblicazione: (2026)

Perceptions of anti‐obesity medications among people with obesity and healthcare providers in the US: Findings from the OBSERVE Study
di: Lee M. Kaplan, et al.
Pubblicazione: (2025)

Exploring the Role of Internalized Weight Bias as a Metric of Cumulative Social Disadvantage Among People With Obesity or Overweight: Insights From the OBSERVE Study
di: Jamy Ard, et al.
Pubblicazione: (2025)

Response to Hayashi et al.
di: Corby K. Martin, et al.
Pubblicazione: (2025)

Efficacy and safety of a novel oral hydrogel capsule in adults with overweight or obesity: the pivotal randomized RESET study
di: Jamy D. Ard, et al.
Pubblicazione: (2025)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
di: Faith Anne N. Heeren, et al.
Pubblicazione: (2025)

Efficacy of Oral Antiobesity Medications With Versus Without Adjunct Behavioral Weight Management Treatment
di: Rebecca A. Jones, et al.
Pubblicazione: (2026)

Adolescent experiences of weight‐related communication: Sociodemographic differences and the role of parents
di: Leah M. Lessard, et al.
Pubblicazione: (2024)

Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study
di: Leslie J. Heinberg, et al.
Pubblicazione: (2025)

GLP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials
di: Kristen M. Beavers, et al.
Pubblicazione: (2024)

A Novel Method to Evaluate Insulin Sensitivity by Combining Continuous Glucose Monitoring and Urinary C‐Peptide Excretion
di: Guillermo Sanchez‐Delgado, et al.
Pubblicazione: (2026)

Psychosocial Outcomes in Telemedicine and Long‐Acting Incretin‐Specific Behavioral Intervention
di: Leslie J. Heinberg, et al.
Pubblicazione: (2026)

Glucagon‐like peptide ‐1 receptor agonist ‐based agents and weight loss composition: Filling the gaps
di: Robert L. Dubin, et al.
Pubblicazione: (2024)

Nutritional considerations with antiobesity medications
di: Jaime P. Almandoz, et al.
Pubblicazione: (2024)

Response to the Letter to the Editor by Bett et al.
di: Jaime P. Almandoz, et al.
Pubblicazione: (2024)

Response to the Letter to the Editor by Athinarayanan
di: Jaime P. Almandoz, et al.
Pubblicazione: (2024)

Four‐year follow‐up of weight loss maintenance using electronic medical record data: The PROPEL trial
di: Peter T. Katzmarzyk, et al.
Pubblicazione: (2024)

Clarification of our response to “The importance of diversity in Obesity articles”
di: Michelle Cardel, et al.
Pubblicazione: (2024)

Valuing behavioral interventions for obesity reduction: A scoping review of economic models
di: Joanna McLaughlin, et al.
Pubblicazione: (2024)

Tirzepatide for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN
di: Deborah B. Horn, et al.
Pubblicazione: (2025)

Comparative Weight Change With Initiation and Adherence to Common Medications for Type 2 Diabetes
di: Nadia M. Sneed, et al.
Pubblicazione: (2025)

How Do Trauma‐ and Violence‐Informed Care Approaches Underpin Bariatric Surgery Interventions for Type 2 Diabetes Mellitus Remission? A Scoping Review
di: Michelle Greenway, et al.
Pubblicazione: (2025)

Association of Obesity Severity With Cardiometabolic and Renal Disease Burden in the United States
di: Florina Corpodean, et al.
Pubblicazione: (2025)

Estimated Glucose Disposal Rate and Risk of Vascular Events and Death in Type 2 Diabetes in the ADVANCE Study
di: Ruirui Wang, et al.
Pubblicazione: (2026)

Impact of Real Time, Flash and Retrospective Continuous Glucose Monitoring on Feto‐Maternal Outcomes in Women With Gestational Diabetes and Pre‐Gestational Diabetes: A Systematic Review and Meta‐Analysis With Trial Sequential Analysis of Randomized Controlled Trials
di: Deep Dutta, et al.
Pubblicazione: (2026)

The One‐Hour Oral Glucose Tolerance Test to Predict Glucose Intolerance Postpartum in Women With Prior Gestational Diabetes
di: Niels Bochanen, et al.
Pubblicazione: (2026)

Glucose‐Dependent Insulinotropic Polypeptide and Glucagon After Weight Loss Induced by Diet or Bariatric Surgery
di: Amanda Finn, et al.
Pubblicazione: (2025)

Cardiovascular Disease Risk Prediction in Patients With Metabolic Dysfunction‐Associated Steatohepatitis
di: Joe Hollinghurst, et al.
Pubblicazione: (2026)

Efficacy and Safety of Tirzepatide on Weight Loss in Patients Without Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
di: Sharath Kommu, et al.
Pubblicazione: (2025)

Cardiorenal Outcomes of Sodium–Glucose Cotransporter 2 Inhibitors in Type 2 Diabetes Mellitus With Nephrotic‐Range Proteinuria: A Multi‐Institutional Target Trial Emulation
di: Jia‐Jin Chen, et al.
Pubblicazione: (2026)

Stem Cell Secretome Treatment Reduces Adiposity and Improves Glucose Handling During Obesity and Weight Loss in Mice
di: Zachary J. Fennel, et al.
Pubblicazione: (2025)

Early Weight Loss and Other Factors Associated With Clinically Significant Weight Loss in Two Commercial Weight Loss Programmes
di: Christopher D. Coleman, et al.
Pubblicazione: (2025)

Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study
di: Jaehyun Bae, et al.
Pubblicazione: (2026)

Disseminating and Implementing the Science of Pediatric Obesity Treatment and Prevention
di: Amanda E. Staiano, et al.
Pubblicazione: (2026)

Long‐Term Weight Loss Outcomes in a Virtual Weight Care Clinic Prescribing a Broad Range of Medications Alongside Behavior Change
di: Jennifer M. Clark, et al.
Pubblicazione: (2025)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
di: Hao Dai, et al.
Pubblicazione: (2025)

Continuous Glucose Monitoring in Adults With Diabetes Receiving Haemodialysis: Identifying Dialysis‐Specific Glycaemic Patterns and Associations With Volume Status and Intradialytic Hypoglycaemia
di: Alexandros L. Liarakos, et al.
Pubblicazione: (2026)